| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.007 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |